Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extracorporeal Magnetic Innervation with Mirabegron for OAB
NCT06123364Completed
- Start
- Oct 2019
- Primary completion
- Apr 2023
- Countries
- 1
01
Overview
Randomised, single-blind trial (2 arms). Primary endpoint: Change in the rate of urgency incontinence episodes at 8 weeks. Started Oct 2019; status: completed.
Beyond the preview
Go deeper on NCT06123364.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06123364.